about
Fibroblast growth factor 1Annexin A2IQ motif containing GTPase activating protein 1S100 calcium binding protein BCalcyclin binding proteinATPase sarcoplasmic/endoplasmic reticulum Ca2+ transporting 2Putative annexin A2-like proteinS100 calcium binding protein A6AHNAK nucleoproteinPotassium two pore domain channel subfamily K member 3Annexin A11S100 calcium binding protein A11S100 calcium binding protein A1Annexin A11EzrinAdvanced glycosylation end product-specific receptorPotassium channel, subfamily K, member 3ATPase, Ca++ transporting, cardiac muscle, slow twitch 2S100 calcium binding protein A6 (calcyclin)Calcyclin binding proteinIQ motif containing GTPase activating protein 1S100 protein, beta polypeptide, neuralS100 calcium binding protein A11S100 calcium binding protein A1EzrinAdvanced glycosylation end-product specific receptorAnnexin A2Potassium two pore domain channel subfamily K member 3S100 calcium binding protein A6S100 calcium binding protein A1Fibroblast growth factor 1Annexin A2Calcyclin binding proteinATPase sarcoplasmic/endoplasmic reticulum Ca2+ transporting 2EzrinS100 calcium binding protein BAnnexin A11IQ motif containing GTPase activating protein 1Uncharacterized protein Dmel_CG3226Annexin A11b
P680
Calcyclin (S100A6) regulates pulmonary fibroblast proliferation, morphology, and cytoskeletal organization in vitroEzrin interacts with the scaffold protein IQGAP1 and affects its cortical localizationS100A6 binds to annexin 2 in pancreatic cancer cells and promotes pancreatic cancer cell motilityA novel calcium-sensitive switch revealed by the structure of human S100B in the calcium-bound form
P921
Q14889337-4471EE15-DAA0-4500-BEA5-372F995C0ACCQ14908237-0232A9FD-1BBF-4BC4-9617-C449D949FA0DQ14908237-A9142192-06DE-427A-AE08-9196E1C38296Q21096417-803F900C-3FBF-435D-977C-1FCCB4803D56Q21108021-438272CB-765B-449B-BE2B-C6D4C1C282E0Q21108520-1ED9A804-7AFD-4902-B724-70E046A20E28Q21115319-F1706A7C-471D-4110-B23C-364C81221704Q21115367-A30A59B9-8B7D-4BD3-A63F-668FE9B990C3Q21115897-065ABB40-542B-4239-87D4-E962E1252116Q21116466-43E80BBC-93C7-4C6E-ADB2-4D05BE09303AQ21119816-37E1FC51-E7CB-42CF-9A6E-0ACB7172BF69Q21130004-8BA9E201-9861-48B2-9D6C-0FF408410935Q21130004-C64B8E32-AC4A-42D4-97DF-7CC30F1ECD6BQ21134492-A103FD6F-8C16-4B88-AD3A-B21319662BCFQ21171227-0642A2FD-2A0E-4DF8-9E64-2302C67A49E2Q21494842-D0824684-ED52-455C-8EAF-672725C52C85Q21494842-EB00082E-A8FF-449D-B1C9-D27F403B9464Q21496347-86E2B26A-9D99-4B0E-B8F9-91A92CB38AF9Q21496784-42123374-C7AB-417D-A074-9C12BA2E887DQ21497870-C4AB5204-DFDD-41F4-81CD-242551AE8121Q21499088-340E10BD-31FA-44A2-AABA-0499DAC442DFQ21981704-9EB2B24C-77C8-4197-BBE0-BF263E6E083AQ21981706-6EFCAD1A-4075-43F0-8104-7F82927B8485Q21985377-3BB8D75F-8015-4AAE-B4D0-971AD5F23983Q21986746-3E26D6B3-376C-499D-BA90-81E92AF4F856Q21986747-48A99E5B-7454-49B9-938D-AEFF36199C53Q21986749-642243AC-B5AE-4061-8F93-2674BF452FFBQ22679669-3E71FAF4-6FBB-4369-856B-A1FA420F2955Q22683568-87282106-D241-475A-A11E-4BF9D3DD2DF5Q2851537-3201DD7B-7703-4AB1-8794-190F7C4CAC7AQ2851537-53B97BA4-670A-4620-8442-2BAFD030BC67Q28556319-DFEED833-3CD6-4304-97B7-1B6AF42E4B95Q28557100-9026289A-21ED-4423-830E-57BB58FEDACAQ28558129-446028FB-EE6F-45E0-B49B-A98F586417DAQ28559432-E73488FA-E97D-45F7-ACB0-836AEE9FB238Q28559529-99B586D9-BD20-48D6-B18C-E83E74DFE90AQ28559858-A0478ADB-76D0-42A0-A0FC-BD2F509B329BQ28560282-A1500983-B09F-4FF7-B530-7F90F464CF75Q28562542-F1EA1269-53D2-4651-9664-B701E433EB51Q28562583-887A8ECC-B925-4F0A-B9E2-D688AC77702D
P680
description
Interacting selectively and no ...... isease, Down Syndrome and ALS.
@en
moleculaire functie
@nl
name
S100 protein binding
@en
type
label
S100 protein binding
@en
altLabel
GO:0044548
@en
S100 binding
@en
prefLabel
S100 protein binding
@en
P279
P2888
P686
GO:0044548